Header Logo

Cheryl Bushnell

Concepts (347)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
82
2019
539
18.400
Why?
Brain Ischemia
23
2018
133
5.510
Why?
Women's Health
13
2014
223
3.410
Why?
Ischemic Attack, Transient
12
2018
40
3.150
Why?
Pregnancy Complications, Cardiovascular
10
2018
21
2.750
Why?
Secondary Prevention
11
2018
61
2.500
Why?
Sex Characteristics
10
2018
173
2.460
Why?
Migraine Disorders
6
2014
61
2.240
Why?
Humans
112
2019
28820
1.860
Why?
Estrogen Replacement Therapy
8
2014
187
1.830
Why?
Female
84
2018
18715
1.760
Why?
Pregnancy Complications
6
2017
78
1.710
Why?
Risk Factors
40
2018
3660
1.630
Why?
Pregnancy
21
2018
758
1.540
Why?
Patient Discharge
10
2019
165
1.320
Why?
Patient Readmission
4
2018
96
1.220
Why?
Pre-Eclampsia
2
2018
54
1.100
Why?
Patient-Centered Care
3
2018
64
1.040
Why?
Aged
42
2018
9941
0.990
Why?
Anticoagulants
7
2018
130
0.970
Why?
Hypertension, Pregnancy-Induced
2
2018
9
0.920
Why?
Middle Aged
42
2018
11394
0.910
Why?
Postpartum Period
3
2018
32
0.900
Why?
Hospitals
6
2019
69
0.880
Why?
Venous Thrombosis
3
2018
46
0.850
Why?
United States
25
2019
3708
0.830
Why?
Primary Prevention
3
2014
50
0.820
Why?
Vasospasm, Intracranial
1
2019
10
0.820
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2017
145
0.820
Why?
Vasoconstriction
1
2019
41
0.810
Why?
Cerebrovascular Disorders
1
2019
56
0.790
Why?
Intracranial Thrombosis
3
2014
8
0.770
Why?
Subacute Care
1
2018
8
0.760
Why?
Hypertension
6
2018
981
0.760
Why?
Male
41
2018
18406
0.760
Why?
Brain Diseases
1
2018
37
0.730
Why?
Thrombolytic Therapy
1
2017
54
0.710
Why?
Vascular Diseases
2
2009
72
0.690
Why?
Practice Guidelines as Topic
5
2019
374
0.680
Why?
Research Design
5
2018
280
0.670
Why?
Nurse Practitioners
1
2016
8
0.660
Why?
Mobility Limitation
1
2017
189
0.640
Why?
Cardiovascular Diseases
7
2014
1092
0.640
Why?
Aged, 80 and over
18
2017
3878
0.640
Why?
Depression
4
2017
381
0.640
Why?
Patient Education as Topic
5
2018
239
0.630
Why?
Upper Extremity
1
2015
51
0.600
Why?
American Heart Association
7
2014
93
0.600
Why?
Antineoplastic Agents, Hormonal
2
2005
38
0.600
Why?
Severity of Illness Index
4
2014
898
0.590
Why?
Tamoxifen
2
2005
53
0.590
Why?
Lower Extremity
1
2015
74
0.590
Why?
Menopause
3
2017
86
0.580
Why?
Antidepressive Agents
2
2012
78
0.570
Why?
Societies, Medical
2
2019
142
0.570
Why?
Cerebral Hemorrhage
4
2018
53
0.560
Why?
Guidelines as Topic
1
2014
44
0.560
Why?
Registries
7
2017
302
0.540
Why?
Aspirin
6
2018
60
0.530
Why?
Atrial Fibrillation
5
2017
302
0.520
Why?
Hospitals, Community
1
2012
8
0.510
Why?
Hyperlipidemias
3
2014
55
0.480
Why?
Quality Assurance, Health Care
1
2012
65
0.480
Why?
Telemedicine
1
2012
53
0.480
Why?
Continuity of Patient Care
1
2012
57
0.480
Why?
Neurology
3
2012
38
0.480
Why?
Incidence
10
2018
1141
0.470
Why?
Quality of Life
3
2017
840
0.460
Why?
Cerebral Arteries
2
2014
18
0.460
Why?
Pulsatile Flow
3
2015
25
0.460
Why?
Depressive Disorder
1
2011
78
0.460
Why?
Premenstrual Syndrome
1
2010
3
0.450
Why?
Platelet Aggregation Inhibitors
5
2017
92
0.450
Why?
Antihypertensive Agents
4
2018
372
0.440
Why?
Risk
2
2008
307
0.430
Why?
Models, Statistical
1
2011
160
0.420
Why?
Treatment Outcome
12
2018
3132
0.420
Why?
Life Change Events
1
2009
18
0.400
Why?
Appointments and Schedules
1
2009
19
0.400
Why?
Puerperal Disorders
3
2017
6
0.400
Why?
Prognosis
7
2018
1394
0.400
Why?
Time Factors
12
2018
2077
0.400
Why?
Randomized Controlled Trials as Topic
4
2011
447
0.390
Why?
Prevalence
5
2018
962
0.380
Why?
Headache Disorders, Primary
1
2008
4
0.380
Why?
Healthcare Disparities
4
2017
123
0.380
Why?
Hospitalization
5
2017
364
0.370
Why?
Adult
16
2018
8605
0.360
Why?
Longitudinal Studies
9
2017
744
0.360
Why?
Thrombectomy
2
2018
56
0.360
Why?
Case-Control Studies
5
2014
913
0.350
Why?
Follow-Up Studies
7
2018
2166
0.330
Why?
Medication Adherence
4
2018
136
0.330
Why?
Somatoform Disorders
1
2005
9
0.320
Why?
Risk Assessment
11
2017
1347
0.320
Why?
Medicare
2
2019
177
0.320
Why?
Intracranial Hemorrhages
2
2017
33
0.320
Why?
Disability Evaluation
4
2017
224
0.310
Why?
Intracranial Arteriosclerosis
1
2005
11
0.310
Why?
Electroencephalography
1
2005
75
0.310
Why?
Seizures
1
2005
53
0.310
Why?
Clinical Trials as Topic
3
2015
324
0.310
Why?
Magnetic Resonance Imaging
6
2019
1242
0.310
Why?
Recovery of Function
4
2017
212
0.300
Why?
Retrospective Studies
6
2018
2921
0.300
Why?
Internship and Residency
1
2009
271
0.300
Why?
Selective Estrogen Receptor Modulators
1
2004
28
0.290
Why?
Tetrazoles
2
2015
100
0.290
Why?
Economics, Pharmaceutical
1
2004
5
0.290
Why?
Prospective Studies
8
2017
2007
0.290
Why?
Anticholesteremic Agents
1
2004
39
0.280
Why?
Emergency Medical Services
2
2019
140
0.280
Why?
Estrogens
1
2005
198
0.270
Why?
Age Factors
6
2012
1179
0.270
Why?
Thrombophilia
1
2003
8
0.270
Why?
Contraceptives, Oral, Hormonal
2
2018
7
0.270
Why?
North Carolina
5
2019
1741
0.260
Why?
Odds Ratio
6
2017
477
0.260
Why?
Patient Selection
3
2018
258
0.260
Why?
Homocysteine
1
2002
17
0.260
Why?
Caregivers
3
2018
74
0.260
Why?
Blood Coagulation Tests
1
2002
7
0.250
Why?
Comorbidity
4
2014
554
0.250
Why?
Blood Coagulation Disorders
1
2002
9
0.250
Why?
Predictive Value of Tests
5
2017
802
0.240
Why?
Mass Screening
1
2003
201
0.230
Why?
Estrogens, Conjugated (USP)
2
2014
125
0.230
Why?
Fibrinolytic Agents
2
2011
63
0.230
Why?
Breast Neoplasms
2
2005
718
0.220
Why?
Disabled Persons
2
2014
84
0.220
Why?
Activities of Daily Living
2
2014
238
0.220
Why?
Ultrasonography, Doppler, Transcranial
3
2015
26
0.220
Why?
Gene Expression
2
2012
328
0.210
Why?
Gene Expression Regulation
2
2014
485
0.210
Why?
Gene Expression Profiling
5
2014
333
0.210
Why?
Organizational Policy
1
2019
21
0.200
Why?
Prenatal Care
2
2017
33
0.200
Why?
Certification
1
2019
22
0.200
Why?
Linear Models
3
2017
453
0.200
Why?
Clinical Competence
1
2002
301
0.200
Why?
Pilot Projects
2
2012
470
0.200
Why?
Health Status Indicators
2
2009
76
0.200
Why?
Data Mining
1
2018
7
0.190
Why?
Health Policy
1
2019
72
0.190
Why?
Ethics, Research
1
2018
28
0.190
Why?
Drug Therapy, Combination
3
2014
306
0.190
Why?
Tissue Plasminogen Activator
1
2018
36
0.190
Why?
Syndrome
1
2018
68
0.190
Why?
Endarterectomy, Carotid
1
2017
27
0.180
Why?
Delivery, Obstetric
1
2018
49
0.180
Why?
Professional Practice
1
2017
24
0.180
Why?
Skilled Nursing Facilities
1
2017
8
0.180
Why?
Delivery of Health Care, Integrated
1
2018
24
0.180
Why?
Informed Consent
1
2018
56
0.180
Why?
Cardiomyopathies
1
2018
50
0.180
Why?
Public Health Practice
1
2017
10
0.180
Why?
Women's Rights
1
2017
4
0.180
Why?
Sex Distribution
2
2014
199
0.170
Why?
Electronic Health Records
1
2018
114
0.170
Why?
Myocardial Ischemia
1
2017
94
0.170
Why?
Chronic Disease
2
2015
387
0.170
Why?
Quality Indicators, Health Care
1
2017
54
0.170
Why?
Cohort Studies
3
2011
1721
0.170
Why?
Expert Testimony
1
2015
11
0.160
Why?
Evidence-Based Medicine
3
2014
193
0.160
Why?
African Americans
2
2015
1631
0.160
Why?
Home Care Services
1
2016
38
0.160
Why?
Health Status
3
2018
398
0.160
Why?
Uric Acid
1
2015
27
0.160
Why?
Educational Status
2
2014
171
0.160
Why?
Diagnosis, Differential
2
2009
508
0.160
Why?
Histoplasmosis
1
2015
2
0.160
Why?
Adolescent
6
2012
3176
0.150
Why?
Vasculitis
1
2015
24
0.150
Why?
Sex Factors
1
2017
692
0.150
Why?
Blood Pressure
3
2014
896
0.150
Why?
Basilar Artery
1
2014
8
0.150
Why?
Leukoencephalopathies
1
2014
5
0.150
Why?
Middle Cerebral Artery
1
2014
11
0.150
Why?
Algorithms
1
2018
457
0.150
Why?
Causality
1
2014
35
0.150
Why?
Intracranial Embolism
1
2014
9
0.150
Why?
Coronary Disease
2
2008
240
0.150
Why?
Health Services for the Aged
1
2014
28
0.150
Why?
Life Style
2
2014
383
0.140
Why?
Leukocytes
1
2014
49
0.140
Why?
Risk Adjustment
1
2014
27
0.140
Why?
Income
1
2014
42
0.140
Why?
Hypercholesterolemia
1
2014
66
0.140
Why?
Risk Reduction Behavior
1
2014
110
0.140
Why?
Employment
1
2014
47
0.140
Why?
Proportional Hazards Models
3
2017
763
0.140
Why?
Tomography, X-Ray Computed
1
2019
931
0.130
Why?
Ischemia
1
2014
88
0.130
Why?
Image Interpretation, Computer-Assisted
1
2014
117
0.130
Why?
Reperfusion
1
2012
14
0.130
Why?
Young Adult
2
2017
2402
0.130
Why?
Quality of Health Care
1
2014
149
0.130
Why?
Chromosomes, Human, Y
1
2012
2
0.130
Why?
Chromosomes, Human, X
1
2011
12
0.120
Why?
African Continental Ancestry Group
1
2013
409
0.120
Why?
Program Evaluation
1
2012
177
0.120
Why?
Feasibility Studies
1
2012
261
0.120
Why?
Brain
3
2015
964
0.120
Why?
Tryptamines
1
2010
3
0.110
Why?
Oligonucleotide Array Sequence Analysis
4
2012
165
0.110
Why?
Naproxen
1
2010
8
0.110
Why?
National Institutes of Health (U.S.)
1
2010
29
0.110
Why?
Obsessive Behavior
1
2010
3
0.110
Why?
Logistic Models
3
2017
773
0.110
Why?
Menstrual Cycle
1
2010
34
0.110
Why?
Cognition
1
2015
537
0.110
Why?
Nervous System Diseases
1
2010
35
0.110
Why?
Factor Analysis, Statistical
1
2010
78
0.110
Why?
Primary Health Care
1
2012
164
0.110
Why?
Physical Therapy Modalities
1
2010
72
0.110
Why?
Urban Population
1
2011
76
0.110
Why?
Fetus
1
2010
74
0.110
Why?
Behavior Therapy
1
2010
91
0.110
Why?
Hormone Replacement Therapy
2
2015
90
0.110
Why?
Cognition Disorders
2
2015
417
0.100
Why?
Mental Disorders
1
2010
110
0.100
Why?
Health Personnel
1
2010
109
0.100
Why?
Confidence Intervals
1
2009
146
0.100
Why?
Analgesics
1
2010
122
0.100
Why?
Medroxyprogesterone Acetate
1
2009
89
0.100
Why?
Multicenter Studies as Topic
1
2009
95
0.100
Why?
Contraceptives, Oral
1
2008
20
0.100
Why?
Psychometrics
1
2009
137
0.100
Why?
Biomedical Research
1
2010
164
0.100
Why?
Teaching
1
2009
54
0.100
Why?
Frail Elderly
1
2009
62
0.100
Why?
Cost-Benefit Analysis
2
2011
155
0.100
Why?
Rural Population
1
2011
332
0.090
Why?
Regression Analysis
1
2009
307
0.090
Why?
European Continental Ancestry Group
1
2013
1352
0.090
Why?
Pregnancy Outcome
1
2008
49
0.090
Why?
Canada
2
2017
50
0.090
Why?
Dementia
1
2009
216
0.090
Why?
Patient Compliance
1
2009
216
0.090
Why?
Endometriosis
1
2007
63
0.080
Why?
Diabetes Complications
1
2008
203
0.080
Why?
Postmenopause
2
2009
412
0.080
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2006
41
0.080
Why?
Analysis of Variance
2
2009
487
0.080
Why?
Videotape Recording
1
2005
12
0.080
Why?
Epilepsy
1
2005
50
0.080
Why?
Carotid Arteries
1
2005
110
0.080
Why?
Statistics as Topic
2
2015
106
0.070
Why?
Warfarin
2
2017
28
0.070
Why?
Aging
2
2009
934
0.070
Why?
Survivors
2
2017
150
0.070
Why?
Atherosclerosis
2
2013
781
0.070
Why?
Patient Satisfaction
2
2018
216
0.070
Why?
Socioeconomic Factors
2
2017
434
0.070
Why?
Guideline Adherence
2
2017
102
0.070
Why?
Double-Blind Method
2
2015
533
0.070
Why?
Oxidative Stress
1
2005
247
0.070
Why?
Embolism
1
2002
7
0.070
Why?
Ethnic Groups
1
2005
543
0.060
Why?
Acute Disease
1
2002
237
0.060
Why?
Reproducibility of Results
2
2014
717
0.060
Why?
Organ Size
2
2014
210
0.060
Why?
Neuropsychological Tests
2
2015
400
0.060
Why?
Health Care Surveys
1
2002
187
0.060
Why?
Inflammation
2
2015
511
0.060
Why?
Academic Medical Centers
1
2002
151
0.060
Why?
Body Mass Index
2
2015
920
0.060
Why?
Myocardial Infarction
1
2004
483
0.050
Why?
Patient Care Team
2
2012
123
0.050
Why?
Aftercare
1
2019
25
0.050
Why?
Diabetes Mellitus
1
2002
425
0.050
Why?
Republic of Korea
1
2018
6
0.050
Why?
Telephone
1
2019
50
0.050
Why?
Preconception Care
1
2017
2
0.050
Why?
Pregnancy in Diabetics
1
2017
2
0.050
Why?
Postnatal Care
1
2017
5
0.050
Why?
Social Behavior
1
2018
63
0.050
Why?
Cost of Illness
1
2018
60
0.050
Why?
Diabetes, Gestational
1
2017
14
0.050
Why?
Coronary Stenosis
1
2017
38
0.050
Why?
Government Programs
1
2017
3
0.050
Why?
Federal Government
1
2017
13
0.040
Why?
International Normalized Ratio
1
2017
4
0.040
Why?
Pyridones
1
2017
10
0.040
Why?
Counseling
1
2017
83
0.040
Why?
Fertility Agents
1
2017
1
0.040
Why?
Contraception
1
2017
11
0.040
Why?
Disease Management
1
2018
128
0.040
Why?
Infertility
1
2017
13
0.040
Why?
Hospitals, Teaching
1
2017
25
0.040
Why?
Pyrazoles
1
2017
64
0.040
Why?
Diabetic Angiopathies
1
2017
158
0.040
Why?
Attitude of Health Personnel
1
2018
168
0.040
Why?
Health Services Research
1
2017
71
0.040
Why?
Chi-Square Distribution
1
2017
310
0.040
Why?
Gene Products, tat
1
2015
1
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
2015
17
0.040
Why?
Stress, Psychological
1
2018
207
0.040
Why?
Mental Status Schedule
1
2015
25
0.040
Why?
Survival Rate
1
2018
830
0.040
Why?
Multivariate Analysis
1
2017
700
0.040
Why?
Inflammation Mediators
1
2015
100
0.040
Why?
Erythroblasts
1
2014
1
0.040
Why?
Megakaryocytes
1
2014
3
0.040
Why?
Health Knowledge, Attitudes, Practice
1
2018
336
0.040
Why?
Vascular Resistance
1
2014
32
0.040
Why?
Gene Regulatory Networks
1
2014
28
0.040
Why?
Child
2
2011
2042
0.040
Why?
Work
1
2014
5
0.040
Why?
Retirement
1
2014
11
0.040
Why?
Sample Size
1
2014
39
0.040
Why?
Models, Organizational
1
2014
22
0.040
Why?
Neutrophils
1
2014
103
0.030
Why?
Molecular Sequence Data
1
2014
339
0.030
Why?
Monocytes
1
2014
112
0.030
Why?
Heart Diseases
1
2014
112
0.030
Why?
Age Distribution
1
2013
208
0.030
Why?
Transcription Factors
1
2014
183
0.030
Why?
Sensitivity and Specificity
1
2014
533
0.030
Why?
Specialties, Nursing
1
2012
1
0.030
Why?
Interviews as Topic
1
2013
321
0.030
Why?
Residence Characteristics
1
2013
162
0.030
Why?
alpha-Galactosidase
1
2011
3
0.030
Why?
Ticlopidine
1
2011
18
0.030
Why?
RNA
1
2011
75
0.030
Why?
Protein Processing, Post-Translational
1
2011
69
0.030
Why?
Social Class
1
2011
72
0.030
Why?
Advisory Committees
1
2010
36
0.030
Why?
Up-Regulation
1
2011
200
0.030
Why?
Emergencies
1
2010
43
0.030
Why?
Brain Injuries
1
2010
91
0.030
Why?
Statistics, Nonparametric
1
2009
135
0.030
Why?
Drug Administration Schedule
1
2009
271
0.020
Why?
Dose-Response Relationship, Drug
1
2009
668
0.020
Why?
Reference Values
1
2007
241
0.020
Why?
Headache
1
2007
81
0.020
Why?
Continental Population Groups
1
2007
247
0.020
Why?
Oximes
1
2004
6
0.020
Why?
Heart Failure
1
2011
644
0.020
Why?
Piperidines
1
2004
121
0.020
Why?
Smoking
1
2007
455
0.020
Why?
Attitude to Health
1
2004
139
0.020
Why?
Survival Analysis
1
2004
471
0.020
Why?
Cross-Sectional Studies
1
2007
1356
0.020
Why?
Hispanic Americans
1
2011
1119
0.020
Why?
Animals
1
2011
7492
0.010
Why?
Bushnell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (347)
Explore
_
Co-Authors (16)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_